Skip to main content
. 2017 Dec 14;7:17595. doi: 10.1038/s41598-017-18034-1

Figure 3.

Figure 3

WJ MSCs from obese donor show significantly higher immunomodulatory potential than the cells from non-obese donors. WJ MSC from obese donors (n = 7) inhibited phytohemagglutinin-stimulated human PBMC proliferation in dose-dependent manner in a similar fashion as the BM MSC. The data were analysed using Two-sample Wilcoxon rank-sum (Mann-Whitney) test. Confidence interval for median difference was calculated using Bootstrap method. Immunomodulatory potential of the cells from non-obese donors (n = 7) was significantly lower at 1:10 (**p ≤ 0.01), 1:20 (**p ≤ 0.01) and 1:40 (*p ≤ 0.05) MSC:PBMC ratios.